The Role of Protein Kinases A and C Pathways in the Regulation of Mitogen-Activated Protein Kinase Activation in Response to Gonadotropin-Releasing Hormone Receptor Activation-Reference-Cited by-同舟云学术

The Role of Protein Kinases A and C Pathways in the Regulation of Mitogen-Activated Protein Kinase Activation in Response to Gonadotropin-Releasing Hormone Receptor Activation

Published:1999-05-01 Issue:5 Volume:140 Page:2241-2251
ISSN:0013-7227
Container-title:Endocrinology
language:en
Short-container-title:

Author:

Han Xin-bing¹,Conn P. Michael¹²

Affiliation:

1. Oregon Regional Primate Research Center (X.-B.H., P.M.C.), Oregon Health Sciences University, Beaverton, Oregon 97006

2. Department of Physiology and Pharmacology, Oregon Health Sciences University (P.M.C.), Portland, Oregon 97201

Publisher

The Endocrine Society

Subject

Endocrinology

Link

http://academic.oup.com/endo/article-pdf/140/5/2241/10378459/endo2241.pdf

Reference50 articles.

1. MAPKs: new JNK expands the group;Davis;Trends Biochem Sci,1994

2. How MAP kinases are regulated;Cobb;J Biol Chem,1995

3. Mitogenic signaling via G protein-coupled receptors;Biesen;Endocr Rev,1996

4. Monoclonal antibodies against epidermal growth factor receptor induce prolactin synthesis in cultured rat pituitary cells (GH3);Hapgood;Proc Natl Acad Sci USA,1983

5. Functional and morphological characterization of four cell lines derived from GH3 cells stably transfected with gonadotropin-releasing hormone receptor complementary deoxyribonucleic acid;Stanislaus;Endocrinology,1994

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. C-Src Is Activated by the EGF Receptor in a Pathway that Mediates JNK and ERK Activation by Gonadotropin-Releasing Hormone in COS7 Cells;International Journal of Molecular Sciences;2020-11-13

2. Molecular Mechanisms of Gonadotropin-Inhibitory Hormone (GnIH) Actions in Target Cells and Regulation of GnIH Expression;Frontiers in Endocrinology;2019-02-25

3. A randomised, placebo-controlled, multicentre, Phase 2 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia;BJU International;2018-05-04

4. Consider the context: Ras/ERK and PI3K/AKT/mTOR signaling outcomes are pituitary cell type-specific;Molecular and Cellular Endocrinology;2018-03

5. Gonadotropins;Endocrinology;2017